FAZI, Paola
 Distribuzione geografica
Continente #
NA - Nord America 723
EU - Europa 514
AS - Asia 182
SA - Sud America 7
AF - Africa 4
Totale 1.430
Nazione #
US - Stati Uniti d'America 717
IT - Italia 351
SG - Singapore 95
SE - Svezia 49
CN - Cina 47
IN - India 28
DE - Germania 17
RU - Federazione Russa 17
BG - Bulgaria 16
GB - Regno Unito 13
NL - Olanda 9
RO - Romania 8
FI - Finlandia 7
FR - Francia 6
BE - Belgio 5
CA - Canada 5
IE - Irlanda 5
AR - Argentina 4
ID - Indonesia 4
BR - Brasile 3
PH - Filippine 3
TG - Togo 3
AT - Austria 2
ES - Italia 2
HK - Hong Kong 2
LT - Lituania 2
NO - Norvegia 2
UA - Ucraina 2
BT - Bhutan 1
EG - Egitto 1
IL - Israele 1
KZ - Kazakistan 1
LV - Lettonia 1
MX - Messico 1
Totale 1.430
Città #
Fairfield 105
Florence 67
Singapore 63
Woodbridge 61
Rome 54
Ashburn 53
Chandler 51
Seattle 50
Cambridge 46
Houston 38
Santa Clara 38
Milan 33
Wilmington 28
Ann Arbor 21
Princeton 16
Sofia 16
Naples 12
New York 10
Beijing 9
San Paolo di Civitate 8
Plano 7
San Diego 7
Millbury 6
Udine 6
Bologna 5
Bremen 5
Dublin 5
Lawrence 5
London 5
Palermo 5
Bergamo 4
Brussels 4
Federal 4
Helsinki 4
Jakarta 4
Moscow 4
Turin 4
Acerra 3
Andover 3
Boston 3
Campodarsego 3
Casier 3
Dearborn 3
Falls Church 3
Formia 3
Genoa 3
Kunming 3
Lanzo d'Intelvi 3
Lomé 3
Norwalk 3
Ottawa 3
Sassari 3
Treviso 3
Vicenza 3
Abano Terme 2
Alessandria 2
Ancona 2
Bareggio 2
Bari 2
Bengaluru 2
Boardman 2
Bühl 2
Camden 2
Capriva del Friuli 2
Des Moines 2
Falkenstein 2
Freiburg im Breisgau 2
Genazzano 2
Hefei 2
La Spezia 2
Lappeenranta 2
Lido di Ostia 2
Livorno 2
Madrid 2
Montesilvano Marina 2
Nanjing 2
Oslo 2
Portland 2
Porto Alegre 2
Robbiate 2
Salerno 2
Scandicci 2
Spinea 2
Toronto 2
Tribiano 2
Trieste 2
Trumbull 2
Verbania 2
Almaty 1
Anzio 1
Aprilia 1
Augusta 1
Buffalo 1
Cagliari 1
Cairo 1
Caltanissetta 1
Carini 1
Casale Monferrato 1
Caserta 1
Central 1
Totale 994
Nome #
null 120
A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients. Final results of the GIMEMA LAL1509 protocol 107
Addition of venetoclax to FLAI induction chemotherapy (VFLAI) improves survival in patients with intermediate and high-risk AML vs FLAI and 3+7: A GIMEMA Italian cooperative analysis 105
Update of the GIMEMA MDS0306 study: Deferasirox for lower risk transfusion-dependent patients with myelodysplastic syndromes 87
High-Dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: Results of the EORTC-GIMEMA AML-12 trial 72
null 58
null 55
null 55
The Addition of Venetoclax to Induction Chemotherapy in No Low-Risk AML Patients: A Propensity Score-Matched Analysis of the Gimema AML1718 and AML1310 Trials 52
null 51
null 51
null 50
Mitoxantrone, Etoposide and Intermediate-dose Ara-c (mec) - An Effective Regimen For Poor Risk Acute Myeloid-leukemia 46
P523: The comparison of VFLAI, FLAI and 3 + 7 regimens by multilevel propensity score weighting highlights the benefit of the addition of venetoclax in no low risk aml treated in Gimema trials real world 44
MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine 43
null 43
null 43
null 40
Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: Final results of the randomized Italian-German APL0406 trial 39
P495: UNLOCKING THE POTENTIAL OF SYNTHETIC PATIENTS FOR ACCELERATING CLINICAL TRIALS: RESULTS OF THE FIRST GIMEMA EXPERIENCE 31
Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996 31
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol 30
Gemtuzumab ozogamicin versus best supportive care in older patients with newly diagnosed acute myeloid leukemia unsuitable for intensive chemotherapy: Results of the randomized phase III EORTC-GIMEMA AML-19 Trial 26
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative 26
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial 25
Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients 25
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients 24
Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease 23
High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT 23
COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey 16
Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies 16
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative 14
A Propensity Score Weighting Analysis Emphasizes the Progress of the Gimema Approach in Adult Ph-Positive Acute Lymphoblastic Leukemia in the TKI Era 13
How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey 12
Final Analysis for the Primary End-Point of Gimema AML1718, a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia 11
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index 7
Digital Twins As Control Groups to Accelerate Assessment of Safety and Efficacy of Novel Treatment Strategies in Ph-Negative Acute Lymphoblastic Leukemia 4
Totale 1.518
Categoria #
all - tutte 4.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.970


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020152 0 0 0 0 0 0 38 39 32 17 15 11
2020/202178 8 9 5 1 5 7 1 8 11 3 11 9
2021/2022233 13 6 8 13 30 10 8 11 19 20 72 23
2022/2023253 31 21 5 19 23 26 13 25 47 4 15 24
2023/2024333 32 25 26 53 39 70 12 9 5 34 10 18
2024/2025288 31 44 16 42 67 50 38 0 0 0 0 0
Totale 1.518